2003•Zhonghua shiyan waike zazhiRequires access

Expression of lung resistance protein and P-glycoprotein (P-gp) in human bladder carcinoma and its clinical significance

Yu Zeng

Open publisher page 0 citations

Abstract

Objective To investigate the expression and clinical significance of lung resistance protein (LRP) and P-glycoprotein (P-gp) in human bladder carcinoma. Methods Sixty-two paraffin-embedded bladder carcinoma specimens were examined by immunohistochemical staining. Results Of the 62 tumor specimens examined, 42 (67.74% ) and 24 (38.71 %) were positively immunostained for LRP and P-gp, respectively. Co-expression of the two proteins was observed in 13 (21.00%) specimens. Positive immunostaning of P-gp was not correlated with tumor stage, cell differentiation and cell proliferation ( P 0. 05), but the study demonstrated a strong relationship between LRP and tumor grade ( rs = - 0.74, P 0. 001). No correlation was found between LRP and P-gp expression. Conclusion LRP appears to be a more effective factor of multidrug resistance assay than P-GP in bladder carcinoma.

About this research paper

What this paper is about

Objective To investigate the expression and clinical significance of lung resistance protein (LRP) and P-glycoprotein (P-gp) in human bladder carcinoma. Methods Sixty-two paraffin-embedded bladder carcinoma specimens were examined by immunohistochemical staining. Results Of the 62 tumor specimens examined, 42 (67.74% ) and 24 (38.71 %) were positively immunostained for LRP and P-gp, respectively. Co-expression of the two proteins was observed in 13 (21.00%) specimens. Positive immunostaning of P-gp was not correlated with tumor stage, cell differentiation and cell proliferation ( P 0. 05), but the study demonstrated a strong relationship between LRP and tumor grade ( rs = - 0.74, P 0. 001). No correlation was found between LRP and P-gp expression. Conclusion LRP appears to be a more effective factor of multidrug resistance assay than P-GP in bladder carcinoma.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the expression and clinical significance of lung resistance protein (LRP) and P-glycoprotein (P-gp) in human bladder carcinoma. Methods Sixty-two paraffin-embedded bladder carcinoma specimens were examined by immunohistochemical staining. Results Of the 62 tumor specimens examined, 42 (67.74% ) and 24 (38.71 %) were positively immunostained for LRP and P-gp, respectively. Co-expression of the two proteins was observed in 13 (21.00%) specimens. Positive immunostaning of P-gp was not correlated with tumor stage, cell differentiation and cell proliferation ( P 0. 05), but the study demonstrated a strong relationship between LRP and tumor grade ( rs = - 0.74, P 0. 001). No correlation was found between LRP and P-gp expression. Conclusion LRP appears to be a more effective factor of multidrug resistance assay than P-GP in bladder carcinoma.

Key concepts: P-glycoprotein, Immunohistochemistry, Multiple drug resistance, Clinical significance, Carcinoma, Pathology, Lung, Staining

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression of lung resistance protein and P-glycoprotein (P-gp) in human bladder carcinoma and its clinical significance — Research Paper | ScholarLens